Short version: the GEE round fixes the main statistical objection. The repeated-measures/clustering problem is mostly resolved, the truncation story is now much clearer, and the dose-response analysis is finally powered. What it does not do is erase the underlying design/pathology issues for Qwen or the old protocol-fidelity/provenance concerns.

**1. Did the hierarchical analysis resolve the prior audit findings?**

- `Clustering`: Mostly yes. The new primary models use GEE with `groups=question_id`; estimated within-question correlation is nontrivial for both models (`rho=0.143` Gemma, `0.118` Qwen). That was a real issue: one borderline primary result did fall away after clustering correction, `Gemma B-O` from marginal `p_adj=0.0468` to GEE `p_adj=0.0885`. No primary Phase 2 contrast flipped direction.
- `Two-part decomposition`: Yes. This is now a real model, not just a descriptive table. The key example is Qwen `B-C`: ITT GEE says `B` is worse (`OR=0.535 [0.439,0.652]`), but the hurdle model shows `B` massively increases extraction failure (`OR=11.577`, `p<0.0001`) while improving conditional accuracy among extracted runs (`OR=1.889`, `p=0.0001`).
- `Truncation mediation`: Mostly yes analytically, not experimentally. For Qwen, longer outputs predict lower accuracy (`eval_count_z beta=-0.587`, `p<0.0001`), more extraction failure (`beta=+1.072`, `p<0.0001`), and ceiling hits strongly reduce correctness (`beta=-1.771`, `p<0.0001`). But mediation is not universal: `B-O` attenuates a lot with length control (`-1.618 -> -0.924`), `B-C` only modestly (`-0.625 -> -0.500`), and `B-I` does not attenuate (`-1.998 -> -2.128`).
- `Dose-response power`: Yes statistically. The old 4-point aggregate test was underpowered; the new trial-level GEE on `1248` obs/model resolves that. Gemma shows a positive slope (`beta_dose=+0.610`, `p=0.0027`), Qwen a negative slope (`beta_dose=-0.641`, `p=0.0001`), with a strong model-by-dose interaction (`beta=-1.251`, `p<0.0001`). The remaining caveat is interpretation: Qwen’s negative slope still looks like context-budget pathology, not a clean “more trace is cognitively worse” result.

**2. What changed vs the marginal OR analysis?**

- No primary Phase 2 contrast changed direction under GEE.
- One primary significance call changed: `Gemma B-O` is no longer significant after Holm under GEE (`OR=1.344`, `p_adj=0.0885`) even though it was marginally significant before.
- A new result appeared for synergy: `Gemma E-(B+D-A)` is now significant (`+1.757 [0.980,2.533]`, `p<0.0001`) whereas the old marginal CI crossed zero. I would still not headline this because Qwen stays opposite and null (`-0.217`, `p=0.5339`) and the contrast is still `B`-involving.
- The biggest substantive changes come from decomposition, not from the clustered ITT model:
  - Qwen `B-C`: ITT negative, conditional-positive (`OR 0.535` ITT vs `1.889` on `correct|extracted`).
  - Qwen `B-O`: ITT strongly favors `O` (`OR=0.198`), but conditional accuracy is null (`OR=0.810`, `p=0.2319`).
  - Qwen `B-I`: still worse even after conditioning (`OR=0.446`, `p=0.0252`), so that one is not just truncation.
- The dose-response result changed the most: both old aggregate trends were nonsignificant; both new trial-level slopes are significant.

**3. Remaining gaps that still block submission**

- The main statistics are no longer the blocker. The blockers are now scope and protocol fidelity.
- If the paper claims a general truth about “thinking tokens” independent of budget, it is still blocked. For Qwen, the new models show the mechanism is heavily length-mediated under an `8192` cap; they do not remove that cap confound experimentally.
- If the paper keeps Phase 3 mechanism claims beyond the within-`L` dose result, it is still blocked. `M` is still compression-plus-stronger-author, `K` is still donor-length/style mismatch, and most P3 anchors are still historical controls (`ollama 0.20.2 -> 0.20.6`, `10 -> 8` reps, blank digests).
- The documents here still do not close the earlier protocol/provenance audits on token matching and generation metadata. If `I/G/J/F` stay central, reviewers can still raise the stale `token_count`, hardcoded `I` denominator, and blank-digest issues.

**4. Paper-ready findings**

- Coherent reasoning beats shuffled reasoning in both models: `C-F` is `OR=13.430 [9.520,18.945]` for Gemma and `17.747 [11.541,27.291]` for Qwen, both `p_adj<0.0001`. Robustness `5/5`.
- Coherent reasoning beats filler tokens in both models: `C-J` is `OR=9.448 [6.283,14.206]` for Gemma and `4.182 [2.883,6.066]` for Qwen, both `p_adj<0.0001`. Robustness `4/5`.
- Expert scaffolds are highly model-specific: `D-C` is huge for Qwen (`OR=17.483 [8.275,36.937]`, `p_adj<0.0001`) and null for Gemma (`OR=1.145 [0.832,1.576]`, `p_adj=0.8036`). Robustness `5/5`.
- Hidden-think effects are model- and budget-dependent, not universal: `B-C` favors `B` for Gemma (`OR=1.529 [1.197,1.952]`, `p_adj=0.0027`) but favors `C` for Qwen in ITT (`OR=0.535 [0.439,0.652]`, `p_adj<0.0001`). Robustness `5/5`.
- For Qwen, the apparent `B-C` ITT deficit is largely a truncation/extraction effect: extraction failure `OR=11.577` for `B-C`, but `correct|extracted OR=1.889` (`p=0.0001`). Robustness `5/5`.
- For Qwen, visible CoT does not beat hidden thinking on reasoning quality once extraction is separated: `B-O` ITT `OR=0.198`, but extraction failure is enormous (`OR≈3.1e16`) and `correct|extracted OR=0.810` (`p=0.2319`). Robustness `5/5`.
- Trace dose has opposite operational slopes under the fixed budget: Gemma `beta=+0.610 [0.211,1.009]`, `p=0.0027`; Qwen `beta=-0.641 [-0.953,-0.329]`, `p=0.0001`; interaction `p<0.0001`. Robustness `4/5`.

**5. Grade update**

- Experimental design: `B-`  
The analysis got better; the design did not. Qwen cap pathology and Phase 3 mechanism confounds are still there.
- Infrastructure/execution: `C`  
No new evidence here that the provenance/token-fidelity issues were actually closed.
- Statistical analysis: `B+`  
This is the big upgrade. GEE clustering, hurdle decomposition, token-length mediation, and trial-level dose modeling address the main audit objections.
- Self-correction: `A`  
They did the analyses the audits asked for and changed the story where the new models forced it.

Net: the project is no longer blocked by the core statistics. It is still blocked if the manuscript keeps broad mechanism claims or leaves the old protocol/provenance audit issues unresolved.